154598-52-4 Efavirenz AKSci J95133
 
 
Loading Please Wait...
  J95133    AKSci Bulk Reagent
Efavirenz, 95%
 
(4S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one, Efavirenz
Stocrin
Sustiva
IDENTITY
CAS Number:154598-52-4
MDL Number:MFCD05662344
MF:C14H9ClF3NO2
MW:315.67
SPECIFICATIONS & PROPERTIES
Min. Purity Spec:95%
Physical Form (at 20°C):Solid
Melting Point:137-141°C
Optical Rotation:-86.0 - -96.0° (c=1, MeOH)
Long-Term Storage:Store long-term at -20°C
DOT/IATA TRANSPORT INFORMATION
Not hazardous material

BIOLOGICAL INFO
Solubility:DMSO: 15 mg/mL, clear
Application(s):Non-nucleoside reverse transcriptase inhibitor (NNRTI)

REVIEW
 Efavirenz is a chiral, single enantiomer non-nucleoside reverse transcriptase inhibitor (NNRTI). Similar to zidovudine, efavirenz inhibits the activity of viral RNA-directed DNA polymerase (i.e., reverse transcriptase). Antiviral activity of efavirenz is dependent on intracellular conversion to the active triphosphorylated form. The rate of efavirenz phosphorylation varies, depending on cell type. It is believed that inhibition of reverse transcriptase interferes with the generation of DNA copies of viral RNA, which, in turn, are necessary for synthesis of new virions. Intracellular enzymes subsequently eliminate the HIV particle that previously had been uncoated, and left unprotected, during entry into the host cell. Thus, reverse transcriptase inhibitors are virustatic and do not eliminate HIV type I from the body. Even though human DNA polymerase is less susceptible to the pharmacologic effects of triphosphorylated efavirenz, this action may nevertheless account for some of the drug''s toxicity.

REFERENCES
[1]Ren J, Bird LE, Chamberlain PP, Stewart-Jones GB, Stuart DI, Stammers DK: Structure of HIV-2 reverse transcriptase at 2.35-A resolution and the mechanism of resistance to non-nucleoside inhibitors. Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14410-5. Epub 2002 Oct 17.
[2] Young, Steven D.; Tran, Lekhanh O.; Britcher, Susan F.; Lumma, William C., Jr.; Payne, Linda S.Preparation of benzoxazinones as inhibitors of HIV reverse transcriptase Eur. Pat. Appl. (1994), EP 582455 A1 19940209.

GLOBALLY HARMONIZED SYSTEM (GHS)

Pictograms

Signal Word
Warning

Hazard Statements
H400

Precautionary Statements
P273

Current as of April 20, 2024


Download SDS Request COA

All products are stocked and shipped from San Francisco Bay Area, California, USA.

⚠️
All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.

These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.

Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.

New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.


CATEGORIES
 APIs and Bioactives > Antivirals;NNRTIs


PubChem